Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 16 | 85909137 | missense variant | A/G | snv |
|
0.810 | 1.000 | 3 | 2011 | 2014 | ||||||||||
|
0.925 | 0.120 | 16 | 85922065 | 3 prime UTR variant | C/T | snv | 0.40 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.810 | 1.000 | 2 | 2013 | 2014 | |||||||
|
1.000 | 16 | 85909053 | missense variant | A/G | snv |
|
0.810 | 1.000 | 2 | 2011 | 2013 | ||||||||||
|
0.882 | 0.200 | 16 | 85910833 | intron variant | A/G;T | snv | 0.35 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.925 | 0.120 | 16 | 85922065 | 3 prime UTR variant | C/T | snv | 0.40 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
16 | 85902784 | 5 prime UTR variant | GGCTGCAGGT/-;GGCTGCAGGTGGCTGCAGGT;GGCTGCAGGTGGCTGCAGGTGGCTGCAGGT | delins |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
16 | 85902784 | 5 prime UTR variant | GGCTGCAGGT/-;GGCTGCAGGTGGCTGCAGGT;GGCTGCAGGTGGCTGCAGGTGGCTGCAGGT | delins |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
1.000 | 0.120 | 16 | 85911217 | intron variant | T/C;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.120 | 16 | 85911217 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
1.000 | 0.120 | 16 | 85911217 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
16 | 85903372 | non coding transcript exon variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
16 | 85903372 | non coding transcript exon variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
16 | 85903372 | non coding transcript exon variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
16 | 85900909 | intron variant | -/T | delins | 0.15 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
16 | 85900909 | intron variant | -/T | delins | 0.15 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 0.200 | 16 | 85910833 | intron variant | A/G;T | snv | 0.35 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.200 | 16 | 85910833 | intron variant | A/G;T | snv | 0.35 |
|
Male Urogenital Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
16 | 85912844 | intron variant | T/C | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
16 | 85912844 | intron variant | T/C | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.040 | 16 | 85899046 | upstream gene variant | C/T | snv | 4.0E-02 |
|
Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 16 | 85899046 | upstream gene variant | C/T | snv | 4.0E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 16 | 85899046 | upstream gene variant | C/T | snv | 4.0E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 16 | 85919323 | intron variant | A/C | snv | 0.63 |
|
Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 16 | 85918076 | intron variant | A/G | snv | 0.13 |
|
Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
16 | 85913869 | intron variant | C/A;T | snv | 9.6E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 |